Connacht Asset Management LP Standard Biotools Inc. Transaction History

Connacht Asset Management LP

  • $16.3 Million
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$3.63 - $6.13 $236,185 - $398,848
-65,065 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$5.5 - $7.41 $663,866 - $894,409
-120,703 Reduced 64.98%
65,065 $429,000
Q2 2021

Aug 16, 2021
SELL
$4.35 - $6.35 $19,583 - $28,587
-4,502 Reduced 2.37%
185,768 $1.14 Million
Q1 2021

May 17, 2021
SELL
$3.94 - $7.09 $193,694 - $348,551
-49,161 Reduced 20.53%
190,270 $860,000
Q4 2020

Feb 12, 2021
BUY
$5.45 - $8.65 $1.3 Million - $2.07 Million
239,431 New
239,431 $1.44 Million

Others Institutions Holding LAB

# of Institutions
143
Shares Held
276M
Call Options Held
27.2K
Put Options Held
34.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $127M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Connacht Asset Management LP Portfolio

Follow Connacht Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Connacht Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email